The effect of growth hormone therapy, adenotonsillectomy and genotype on obstructive sleep apnea in children with Prader-Willi syndrome Source: Annual Congress 2013 –Assessing sleep disordered breathing and lung function in children Year: 2013
Respiration and sleep in young individuals with Prader-Willi syndrome treated with growth hormone Source: Annual Congress 2005 - What should we know about our SAS patients Year: 2005
Treatment of obstructive sleep apnoea syndrome (OSAS) with uvulo palatal flep (UPF) Source: Eur Respir J 2003; 22: Suppl. 45, 96s Year: 2003
Thyroid function and obstructive sleep apnoea – Hypopnoea syndrome (OSAHS) in childhood Source: Annual Congress 2010 - Adenotonsillectomy and paediatric sleep medicine Year: 2010
Fibrinogen level in patients with severe obstructive sleep apnoea syndrome (OSAS). Effect of n-CPAP therapy Source: Eur Respir J 2001; 18: Suppl. 33, 216s Year: 2001
Screening for obstructive sleep apnea (OSA) in acromegaly Source: Virtual Congress 2020 – Screening methods and diagnostic tools for obstructive sleep apnoea Year: 2020
Sleep disordered breathing in Prader Willi syndrome post recombinant human growth hormone therapy Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity Year: 2011
Prevalence of obstructive sleep apnea syndrome in obese children (NANOS study) Source: Annual Congress 2012 - Paediatrics and sleep apnoea/adults and upper airway stimulation Year: 2012
Effect of obstructive sleep apnea syndrome (OSAS) on cognitive performances Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
The impact of obstructive sleep apnea syndrome (SAOS) on serum testosterone level Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
CPAP to treat obstructive sleep apnoea (OSA) in children with Down syndrome (DS) Source: International Congress 2016 – New insights into noninvasive ventilation: between the dream and reality Year: 2016
Frequency of metabolic syndrome (MS) in patients with obstructive sleep apnoea (OSA) depends on adopted definition Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise Year: 2010
Effects of CPAP treatment on physical fitness in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2003; 22: Suppl. 45, 97s Year: 2003
Prevalence of the metabolic syndrome in untreated Mediterranean patients with the obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009
Plasma levels of TNF in obstructive sleep apnea syndrome (OSA) before and after surgical intervention Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012
Secondary hypogonadism induced by severe obstructive sleep apnea syndrome (OSAS) and results after two months CPAP treatment Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010
Evolution of upper airway resistance syndrome (UARS) to obstructive sleep apnoea syndrome (OSAS), a prospective study Source: Eur Respir J 2006; 28: Suppl. 50, 648s Year: 2006
Angio-inhibitory activity and decreased leptin level in sera from obstructive sleep apnea syndrome (OSAS) patients Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001
Transition from obstructive sleep apnea (OSA) to obesity hypoventilation syndrome (OHS) Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies Year: 2015
Cortisol metabolism in obstructive sleep apnea (OSA) Source: Eur Respir J 2002; 20: Suppl. 38, 215s Year: 2002